Liad Hinden

16PUBLICATIONS
69CO-AUTHORS
Surface water quality processes and contaminated sediment assessmentCharacterisation of biological macromoleculesBiologically active moleculesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 24, 2026
Endocannabinoid responses to relief of obstruction in acute injured kidney: a prospective observational study.

|Mar 17, 2026
Progressive endocannabinoid system dysregulation in autosomal dominant polycystic kidney disease.

Shridhar Betkar, Alina Nemirovski, Shmuel Ruppo

|Mar 05, 2026
Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration.

Radka Kočvarová, Shahar Azar, Bella Agranovich

|Jul 24, 2025
Targeting the endocannabinoid system to suppress mTORC1 hyperactivation in TSC-associated kidney disease.

Eden Abergel, Hadass Pri-Chen, Shulamit Wallach-Dayan

|Feb 15, 2025
Correction: Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.

Elise Wreven, María Soledad Ruiz de Adana, Stéphan Hardivillé

|Jun 12, 2024
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.

Elise Wreven, María Soledad Ruiz de Adana, Stéphan Hardivillé

Pageof 3

Frequent Collaborators

15 joint publications

Joseph Tam

4 joint publications

Alina Nemirovski

2 joint publications

Mikael Chetboun

2 joint publications

Stéphan Hardivillé